MoneyWorks4Me

Zim Laboratories informs about details of loss of certificate

22 Jan 2022 Evaluate

Zim Laboratories has informed that as per the Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirement), Regulation 2015, RTA have received request from the shareholder for issue of Duplicate Share Certificate and accordingly, RTA of the Company has marked stop transfer until Duplicate Share Certificate is issued.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..